TriMas Corp

TriMas Corp(TRS)の株式分析

$39.600

-0.297 (-0.75%)終値時点

Loading chart…
高値
40.140
始値
39.880
出来高加重平均価格
39.58
出来高
394.31K
時価総額
1.03B
安値
39.010
売買代金
15.61M
EV/EBITDA(TTM)
5.98

TriMas Corporation designs, manufactures and supplies a range of products for the consumer packaging and industrial markets through its TriMas Packaging and Specialty Products groups. The Company's segments include Packaging and Specialty Products. Its Packaging segment offers dispensing, closure and flexible packaging solutions, including Rieke, Affaba & Ferrari, Taplast, Rapak and Aarts Packaging, along with Intertech and Omega Plastics, which provide life sciences–focused products. Its Packaging business develops and manufactures an array of dispensing products, polymeric and steel caps and closures, polymeric jar products, fully integrated dispensers for fill-ready bag-in-box applications, and consumable vascular delivery and diagnostic test components, all for a variety of consumer products submarkets. Its Specialty Products segment, which includes the Norris Cylinder business, designs, manufactures and distributes highly engineered steel cylinders.

trimas.com

AI分析 of TriMas Corp (TRS)

買い

TriMas Corp (TRS) is a good buy right now due to its current price of 39.6, a strong RSI of 62.109 indicating bullish momentum, and a forward P/E ratio of 19.34 which suggests reasonable valuation compared to growth potential. Additionally, the company has shown a solid year-to-date change of +9.12%, reflecting positive market sentiment. However, a significant risk is the hedge fund selling activity, which has increased by 909.26% over the last quarter, indicating potential concerns among institutional investors.

アナリスト評価(6)

上値余地 +4.80%
中立
1 買い
5 中立
0 売り
現在: 39.60
安値
38.00
平均
41.50
高値
45.00

KeyBanc

2025-11-13

目標株価

$38

オーバーウェイト

KeyBanc

2025-08-13

目標株価

$45

オーバーウェイト

KeyBanc

2025-08-12

目標株価

$45

オーバーウェイト

BWS Financial

2025-07-30

目標株価

$45

買い

BWS Financial

2025-02-28

目標株価

$40

強い買い

バリュエーション指標

TriMas Corp(TRS)の現在の予想PERは19.34で、5年平均は15.05です。

予想PER

適正
5年平均 P/E
15.05
現在のP/E
19.34
割高
19.45
割安
10.65

予想EV/EBITDA

適正
5年平均 EV/EBITDA
8.47
現在のEV/EBITDA
5.98
割高
11.43
割安
5.51

予想PSR

割高
5年平均 P/S
1.36
現在のP/S
2.05
割高
1.74
割安
0.99

Alphio AI による TRS の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%TRS

$24.42

シナリオ価格

基

基本

基本 · 50%TRS

$23.53

シナリオ価格

弱

弱気

弱気 · 25%TRS

$21.04

シナリオ価格

TRS を保有するクジラ

J

Jefferies Financial Group Inc.

+ を保有TRS

+1.22%

3か月リターン

P

Punch & Associates Investment Management, Inc.

+ を保有TRS

-8.65%

3か月リターン

イベントタイムライン

2026-07-30 (ET)

08:30:00

Sees FY26 Sales Growth of 3%-6%

2026-04-30 (ET)

08:10:00

Company Reaffirms 2026 Sales Growth of 3%-6%

08:10:00

TriMas Reports Q1 Revenue of $168.28M

2026-03-16 (ET)

11:40:00

TriMas Completes Aerospace Divestiture for Approximately $1.45B

2026-02-26 (ET)

08:40:00

TriMas Q4 Revenue $155.49M, Below Consensus

ニュース

TRS のよくある質問 — Alphio AI が回答

TriMas Corporation designs, manufactures and supplies a range of products for the consumer packaging and industrial markets through its TriMas Packaging and Specialty Products groups. The Company's segments include Packaging and Specialty Products. Its Packaging segment offers dispensing, closure and flexible packaging solutions, including Rieke, Affaba & Ferrari, Taplast, Rapak and Aarts Packaging, along with Intertech and Omega Plastics, which provide life sciences–focused products. Its Packaging business develops and manufactures an array of dispensing products, polymeric and steel caps and closures, polymeric jar products, fully integrated dispensers for fill-ready bag-in-box applications, and consumable vascular delivery and diagnostic test components, all for a variety of consumer products submarkets. Its Specialty Products segment, which includes the Norris Cylinder business, designs, manufactures and distributes highly engineered steel cylinders. It operates in the Basic Materials sector (METAL FORGINGS & STAMPINGS industry).

TriMas Corp (TRS) is a good buy right now due to its current price of 39.6, a strong RSI of 62.109 indicating bullish momentum, and a forward P/E ratio of 19.34 which suggests reasonable valuation compared to growth potential. Additionally, the company has shown a solid year-to-date change of +9.12%, reflecting positive market sentiment. However, a significant risk is the hedge fund selling activity, which has increased by 909.26% over the last quarter, indicating potential concerns among institutional investors.

6 analysts cover TRS: 1 rate it Buy, 5 Hold and 0 Sell. The average price target is 41.50.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める